Obatay, Baby Boy .
HRN: 22-18-38 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/11/2022
AMPICILLIN 500MG (VIAL)
11/11/2022
11/17/2022
IV
165mg
Q12
PSNB (Thickly MSAF)
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes